These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26195323)

  • 21. Differential gene expression in central nervous system lymphoma.
    Rubenstein JL; Shen A; Batchelor TT; Kadoch C; Treseler P; Shuman MA
    Blood; 2009 Jan; 113(1):266-7; author reply 267-8. PubMed ID: 19122120
    [No Abstract]   [Full Text] [Related]  

  • 22. Melanomas of unknown primary frequently harbor TERT-promoter mutations.
    Egberts F; Krüger S; Behrens HM; Bergner I; Papaspyrou G; Werner JA; Alkatout I; Haag J; Hauschild A; Röcken C
    Melanoma Res; 2014 Apr; 24(2):131-6. PubMed ID: 24463461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of TERT promoter mutations in primary gastric cancer.
    Liu T; Liang X; Björkholm M; Jia J; Xu D
    Gene; 2014 May; 540(2):266-7. PubMed ID: 24583168
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.
    Suh CH; Kim HS; Lee SS; Kim N; Yoon HM; Choi CG; Kim SJ
    Radiology; 2014 Aug; 272(2):504-13. PubMed ID: 24697149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
    Heidenreich B; Nagore E; Rachakonda PS; Garcia-Casado Z; Requena C; Traves V; Becker J; Soufir N; Hemminki K; Kumar R
    Nat Commun; 2014 Feb; 5():3401. PubMed ID: 24569790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.
    Liu X; Wu G; Shan Y; Hartmann C; von Deimling A; Xing M
    Cell Cycle; 2013 May; 12(10):1637-8. PubMed ID: 23603989
    [No Abstract]   [Full Text] [Related]  

  • 27. Epigenetic silencing of multiple genes in primary CNS lymphoma.
    Chu LC; Eberhart CG; Grossman SA; Herman JG
    Int J Cancer; 2006 Nov; 119(10):2487-91. PubMed ID: 16858686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
    Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.
    Zuckerman NS; McCann KJ; Ottensmeier CH; Barak M; Shahaf G; Edelman H; Dunn-Walters D; Abraham RS; Stevenson FK; Mehr R
    Int Immunol; 2010 Nov; 22(11):875-87. PubMed ID: 21059768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous system.
    Gessi M; van de Nes J; Griewank K; Barresi V; Buckland ME; Kirfel J; Caltabiano R; Hammes J; Lauriola L; Pietsch T; Waha A
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):794-7. PubMed ID: 24645797
    [No Abstract]   [Full Text] [Related]  

  • 31. Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.
    Hurst CD; Platt FM; Knowles MA
    Eur Urol; 2014 Feb; 65(2):367-9. PubMed ID: 24035680
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.
    Montesinos-Rongen M; Küppers R; Schlüter D; Spieker T; Van Roost D; Schaller C; Reifenberger G; Wiestler OD; Deckert-Schlüter M
    Am J Pathol; 1999 Dec; 155(6):2077-86. PubMed ID: 10595937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.
    Scholz SL; Thomasen H; Reis H; Möller I; Darawsha R; Müller B; Dekowski D; Sucker A; Schilling B; Schadendorf D; Steuhl KP; Paschen A; Westekemper H; Meller D; Griewank KG
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5854-61. PubMed ID: 26348634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suprasellar lymphoma masquerading as tuberculosis of the central nervous system.
    Dang YL; Hor JY; Chia YK; Lim TT; Eow GB
    Acta Neurol Belg; 2014 Sep; 114(3):239-41. PubMed ID: 23757110
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic lymphoma in patients with the initial diagnosis of primary central nervous system lymphoma: a report of two cases.
    Schwarz S; Schwab S; Harms W; Hacke W
    J Neurol; 1999 Sep; 246(9):855-7. PubMed ID: 10525991
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
    Jangard M; Zebary A; Ragnarsson-Olding B; Hansson J
    Melanoma Res; 2015 Jun; 25(3):185-8. PubMed ID: 25746036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
    Grommes C
    J Clin Oncol; 2023 Mar; 41(9):1649-1651. PubMed ID: 36669147
    [No Abstract]   [Full Text] [Related]  

  • 39. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
    Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
    Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.